Wells Fargo’s ContraFect Corporation CFRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-27
| Closed | -$15 | – | 7860 |
|
|
2023
Q3 | $15 | Buy |
27
+16
| +145% | +$15 | ﹤0.01% | 7304 |
|
|
2023
Q2 | $17 | Buy |
11
+7
| +175% | +$11 | ﹤0.01% | 7341 |
|
|
2023
Q1 | $7 | Buy |
4
+1
| +33% | +$5 | ﹤0.01% | 7567 |
|
|
2022
Q4 | $26 | Hold |
3
| – | – | ﹤0.01% | 7227 |
|
|
2022
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 7947 |
|
|
2022
Q2 | $1K | Hold |
3
| – | – | ﹤0.01% | 6713 |
|
|
2022
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 6948 |
|
|
2021
Q4 | $1K | Hold |
3
| – | – | ﹤0.01% | 7148 |
|
|
2021
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 6898 |
|
|
2021
Q2 | $1K | Sell |
3
-91
| -97% | -$29.8K | ﹤0.01% | 6826 |
|
|
2021
Q1 | $36K | Sell |
94
-421
| -82% | -$182K | ﹤0.01% | 5976 |
|
|
2020
Q4 | $209K | Buy |
515
+124
| +32% | +$53.7K | ﹤0.01% | 5068 |
|
|
2020
Q3 | $165K | Buy |
391
+79
| +25% | +$35.8K | ﹤0.01% | 5049 |
|
|
2020
Q2 | $159K | Buy |
312
+311
| +31,100% | +$153K | ﹤0.01% | 5023 |
|
|
2020
Q1 | $0 | Buy |
+1
| New | +$683 | ﹤0.01% | 7265 |
|
|
2019
Q3 | – | Sell |
-77
| Closed | -$32K | – | 6943 |
|
|
2019
Q2 | $32K | Sell |
77
-35
| -31% | -$13.7K | ﹤0.01% | 5682 |
|
|
2019
Q1 | $35K | Buy |
112
+58
| +107% | +$25.1K | ﹤0.01% | 5404 |
|
|
2018
Q4 | $66K | Buy |
+54
| New | +$85.7K | ﹤0.01% | 5441 |
|
|
2017
Q3 | – | Sell |
-9
| Closed | -$11K | – | 6574 |
|
|
2017
Q2 | $11K | Buy |
+9
| New | +$10.5K | ﹤0.01% | 5770 |
|
Other funds holding CFRX
Wells Fargo's CFRX Position: Q4 2023 in Review
Wells Fargo sold out of ContraFect Corporation (CFRX) in Q4 2023, closing a stake of 27 shares — an estimated $15 sold.
Wells Fargo first reported a position in CFRX in Q2 2017 and held it in 19 quarters. The position peaked at $209K in Q4 2020. 2 funds tracked by Wall St. Rank hold CFRX as of Q4 2023.
- Wells Fargo reported no remaining ContraFect Corporation position as of Q4 2023 after selling out during the quarter.
- Wells Fargo sold 27 ContraFect Corporation shares in Q4 2023, an estimated $15.
- Wells Fargo first reported a position in ContraFect Corporation in Q2 2017 and held it in 19 quarters.
- Wells Fargo's ContraFect Corporation position peaked at $209K in Q4 2020.
- 2 funds tracked by Wall St. Rank held ContraFect Corporation as of Q4 2023.
Based on Wells Fargo's 13F filing for Q4 2023, filed 9 Feb 2024.